DCTH..$1.51..Dual catalyst play. They have an ADCOM in May & an PDUFA date in June. They amended their NDA based on recommendations by the FDA. Smaller market but much better chance of an approval of Chemostat. Market cap is 114m based on the current share price. Like getting positions early. Worked with CLSN when I bought in June which I sold too early at $2.30 in July. I did it with ALXA buying at $1.50 in June and selling at $3.00 in Nov for a 100% gain. The difference is those were data plays and this is a ADCOM/PDUFA play. Same play as TTNP. They can run up to & into the event. They can then exhibit follow through if that ADCOM is positive into the PDUFA date.
Market Data 
Markets 
